
Number of unsuccessful brain cancer drugs in development in the United States from 1998 to 2014
Exclusive Premium Statistic

Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "U.S. pharmaceutical industry"
Popular Related Keywords
- development
- cancer
- abandonment
- cancer drugs
- brain
- Show more
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Cancer patients using medication in select countries 2017
- Average prices of Gleevec - selected countries 2013
- Time from R&D start to approval of select cancer drugs 2017
- Total R&D costs of select cancer drugs 2017
- Unsuccessful attempts and new drugs for cancer types 1998-2014
- Revenue as a part of R&D spending for select cancer drugs 2017
- Revenue since approval for select cancer drugs 2017
- Total R&D costs including costs of capital for select cancer drugs 2017
- Cancer - survival rate of children in the U.S. 1975-2005
- Cancer surgery wait times in Canada in 90th percentile by type 2013 and 2016
- Net price index for cancer products in developed markets 2014
- Anti-cancer drugs estimated market size in South Korea 2014-2020
- Latin America: thyroid cancer market 2016-2021
- Cancer imaging systems market size worldwide forecast 2025
- Cancer specialist input into MCO coverage policy development in U.S. 2015
- Annual new cancer cases and cancer deaths
- Cancer care expenditure distribution in MCOs by service category in U.S. 2015
- Worldwide revenue of cancer drugs
- Cancer drugs on the world market 2010
- Estimated annual cancer cases and deaths worldwide